Anticomplementary properties of cinnarizine.
D000818:Animals; D000936:Antigen-Antibody Complex; D002934:Cinnamates / Q000494:pharmacology; D003169:Complement Inactivator Proteins; D004912:Erythrocytes / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008274:Magnesium; D010587:Phagocytosis / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D011485:Protein Binding; D011817:Rabbits; D014665:Vasodilator Agents / Q000494:pharmacology*
D000936:Antigen-Antibody Complex; D002934:Cinnamates; D003169:Complement Inactivator Proteins; D010879:Piperazines; D014665:Vasodilator Agents; D008274:Magnesium